Atlas Trials

Botulinum Toxin for the Treatment of Depression

Clinical trial NCT00934687 · COMPLETED

Trial details

NCT number
NCT00934687
Sponsor
University Hospital, Basel, Switzerland
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Depression
Start date
2009-08-01
Primary completion
2010-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.